Abstract. The adipose tissue-derived hormone leptin regulates energy balance and neuroendocrine function. Resistance to the appetite-suppressing effects of leptin is associated with common forms of obesity. Here, we review the mechanisms by which leptin activates intracellular signals and the roles that these signals play in CMLS, Cell. Mol. Life Sci. 62 (2005) 642 -652 1420-682X/05/060642-11 DOI 10.1007/s00018-004-4432-1 © Birkhäuser Verlag, Basel, 2005 CMLS Cellular and Molecular Life Sciences leptin action in vivo. Furthermore, we discuss potential mechanisms of leptin resistance, specifically focusing on data regarding the neuroanatomical locus of leptin resistance and potential mechanisms by which expression of the suppressor of cytokine signaling-3 may impair leptin action.
The adipose tissue-derived hormone leptin is produced in proportion to fat stores. Circulating leptin serves to communicate the state of body energy repletion to the central nervous system (CNS) in order to suppress food intake and permit energy expenditure ( fig. 1 ) [1] [2] [3] . Leptin fits the criteria for a feedback signal from body energy stores to the brain as defined by Kennedy [4] in 1953: leptin levels drop during starvation, when fat depots are depleted to support the organism's basic energy needs, and leptin levels rise during refeeding where fat depots are replenished. Furthermore, many of the physiological adaptations triggered by prolonged fasting can be prevented by exogenously administered leptin during the fast, which falsely signals to the brain that energy stores are replete [3, 5, 6] . Adequate leptin levels permit energy expenditure in the processes of reproduction and growth and similarly regulate the autonomic nervous system, other elements of the endocrine system and the immune system [3, 5, 6] . Conversely, lack of leptin signaling due to mutation * Corresponding author.
of leptin (e.g. ob/ob mice) or the leptin receptor (LR) (e.g. db/db mice) in rodents and humans results in increased food intake in combination with a reduced energy expenditure phenotype reminiscent of the neuroendocrine starvation response (including hypothyroidism, decreased growth, infertility and decreased immune function) in spite of their obesity [1, 2, 7, 8] .
LRs and sites of leptin action
There are multiple LR isoforms, all of which are products of a single lepr gene [9, 10] . The lepr gene contains 17 common exons and several alternatively spliced 3¢-exons. In mice, the six distinct LR isoforms that have been identified are designated LRa-LRf. In all species, LR isoforms can be divided into three classes: secreted, short and long. The secreted forms are either products of alternatively spliced messenger RNA (mRNA) species (e.g. murine LRe, which contains only the first 14 exons of lepr) or proteolytic cleaveage products of membranebound forms of LR. These secreted forms contain only extracellular domains that bind circulating leptin, perhaps regulating the concentration of free leptin [11] .
Short form LRs (LRa, LRc, LRd and LRf in mice) and the long form LR (LRb in mice) contain exons 1-17 of lepr and therefore have identical extracellular and transmembrane domains as well as the same first 29 intracellular amino acids, but diverge in sequence thereafter due to the alternative splicing of 3¢ exons. Shortform LRs contain exons 1-17 and truncate 3-11 amino acids after the splice junction. LRc-, LRd-and LRfspecific sequences are not well conserved among species. However, LRa (the most abundantly expressed isoform) is reasonably well conserved, as is LRb, which has an intracellular domain of approximately 300 residues [9, 10] . LRb is crucial for leptin action. Indeed, the originally described db/db mice lack LRb (but not other LR forms) as a consequence of a mutation that causes mis-splicing of the LRb mRNA; these mice display a phenotype that is indistinguishable from that of db 3J /db 3J mice (which are deficient in all LR isoforms) and of leptin-deficient ob/ob animals [3] . The function of short-form LRs is less clear, although proposed roles include the transport of leptin across the blood-brain barrier and the production of circulating LR extracellular domain to complex with leptin. Many of the effects of leptin are attributed to effects in the CNS, particularly in the basomedial hypothalamus, a site of high LRb mRNA expression [12] [13] [14] [15] . Here, leptin acts on neurons that regulate levels of circulating hormones (e.g. thyroid hormone, sex steroids and growth hormone) [12, 16, 17] . Leptin action on these hypothalamic neurons also regulates the activity of the autonomic nervous system, although direct effects of leptin on LRb-containing neurons in the brainstem and elsewhere probably also have an important role [18] . The effects of leptin on the immune system appear to result from direct action on T cells that contain LRb [6] . Leptin might also regulate glucose homeostasis independently of effects on adiposity; leptin regulates glycemia at least partly via the CNS, but it might also directly regulate pancreatic b cells and insulin-sensitive tissues [19] [20] [21] [22] .
Leptin regulation of neural networks and neurophysiology
LRb is present in several tissues, with the highest levels in neurons of several nuclei of the hypothalamus, including the arcuate (ARC), dorsomedial (DMH), ventromedial (VMH) and premammillary nuclei [12] [13] [14] . Other sites within the brain that have been shown to express LRb by in situ hybridization histochemistry for LRb mRNA or by detection of leptin-mediated signaling include the brainstem [nucleus of the solitary tract (NTS) and dorsal motor nucleus of the vagus (DMX)], periaqueductal gray matter and hippocampus. LRb mRNA is highly expressed in the ARC, and LRb signaling is most readily detectable here, as well; LRb is found in at least two distinct populations of ARC neurons. One population synthesizes neuropeptide Y (NPY) and agouti-related peptide (AgRP), and the other synthesizes pro-opiomelanocortin (POMC) [12, 15] . POMC is processed to produce a-melanocyte-stimulating-hormone (aMSH) in LRb/POMC neurons, which signals anorexia (decreased appetite) by activating the melanocortin-4 receptor (MC4R) and to a lesser extent the melanocortin-3 receptor (MC3R) [23] [24] [25] [26] [27] [28] . LRb stimulates the synthesis of POMC and activates/depolarizes LRb/POMC neurons [15, 29] . NPY is an orexigenic (appetite-stimulating) hormone that also suppresses the central LRb-mediated growth and reproductive axes. AgRP is an antagonist of aMSH/MC4R signaling as well as an inhibitor (inverse agonist) of endogenous MC4R activity. Leptin acts via LRb to inhibit NPY/ AgRP neurons and suppress expression of these neuropeptides [15, 29] . Thus, LRb signaling stimulates the production of anorectic neuropeptides and suppresses Figure 1 . Regulation of feeding and neuroendocrine function by leptin. Leptin is secreted from adipocytes as a signal of energy (fat) stores. Circulating leptin activates the long form leptin receptor (LRb) on target cells to regulate energy intake and energy expenditure. Within the brain, two distinct sets of neurons in the arcuate nucleus of the hypothalamus (ARC) are known to be regulated by leptin. The ARC POMC-expressing neuron (an anorexogenic/ appetite-suppressing neuron) is activated by leptin, while the Arc NPY/AgRP neuron (an orexigenic/appetite-stimulating neuron) is inhibited by leptin; the combination of leptin effects on these and other unidentified neurons (labeled '?') mediates the anorectic actions of leptin. The ARC POMC and NPY/AgRP neuron as well as some direct actions of leptin stimulate the TRH neuron to enable the full elaboration of thyroid hormone to permit energy expenditure by modulating the basal metabolic rate (BMR). Leptin also permits energy expenditure by increasing the activity of the sympathetic nervous system (SNS), and stimulating the growth and reproductive axes. Additionally, leptin enables the proliferation of cells required to mount an effective immune response. Thus, leptin sufficiency acts to permit energy expenditure by systems throughout the body, as well as to modulate appetite. [31, 32] . While the minimal phenotype of NPY or AgRP deletion on body weight has led some to suggest a minimal contribution of these neuropeptides to energy homeostasis, it is likely that they substantially affect the response to caloric deprivation, e.g. in fasting or in low-leptin states, as shown for ob/ob and diabetic animals [33, 34] . It is also likely that additional strong counter-regulatory mechanisms act to prevent underfeeding and may compensate for the lack of these neuropeptides. Although ablation of POMC or central melanocortin receptors results in severe obesity [24, 35] , deletion of LRb from POMC neurons results in only modest weight gain [36] . Thus, while melanocortins generally effect a powerful anorectic signal, they may not constitute the majority of the leptin-mediated anorectic signal, which may be mediated by other, potentially unrecognized, populations of LRb-expressing neurons. Indeed, histochemically leptin-sensitive POMC neurons represent only a small subpopulation of the total ARC POMC neurons; conversely, POMC neurons represent only a small fraction of the total leptin-regulated neurons within the ARC [37] , suggesting the presence of significant leptinindependent melanocortin signals and melanocortin-independent leptin function. The functional and neurochemical properties of LRb-regulated neurons in the DMH, VMH and elsewhere (including the brainstem) are poorly characterized.
LR signaling
LRb belongs to the interleukin (IL)-6 receptor family of class 1 cytokine receptors, which contain an extracellular ligand-binding domain a single transmembrane domain, and a cytoplasmic signaling domain [9, 38] . Like other cytokine receptors, LRb does not contain intrinsic enzymatic activity, but instead signals via a non-covalently associated tyrosine kinase of the Jak kinase family (Jak2 in the case of LRb) [39] [40] [41] . Unliganded LRb exists as a pre-formed homodimer; leptin binding alters the conformation of the LRb dimer, enabling transphosphorylation and activation of the intracellular LRb-associated Jak2 molecules [9, 42, 43 ]. The activated Jak2 molecule then phosphorylates other tyrosine residues within the LRb/Jak2 complex to mediate downstream signaling [44, 45] .
Signaling by cytokine receptors requires a proline-rich 'Box 1' motif critical for Jak kinase interaction and activation; additional less-conserved sequences COOHterminal to Box 1 (sometimes referred to as 'Box 2') are also important for Jak kinase interactions and likely function in Jak kinase isoform selectivity [38, 39, 41, 46] . In the case of LRb, intracellular residues 31-36 (i.e. immediately downstream of the alternative splice junction following amino acid 29) compose Box 2 [41, 46] , which is absent from all described short LR isoforms-consistent with the inability of these molecules to mediate leptin action in db/db animals [9, 41, 44] . Tyrosine kinase-dependent signaling generally proceeds via the phosphotyrosine-dependent recruitment of signaling proteins that contain specialized phosphotyrosine binding domains (e.g. SH2 domains) [47] . Each SH2 domain isoform recognizes phosphotyrosine in a specific amino acid context. Thus, while tyrosine phosphorylation acts as a molecular switch to recruit SH2-containing proteins, each tyrosine phosphorylation site recruits only specific SH2 isoforms, since they recognize the surrounding amino acids as well as the phosphotyrosine residue. For instance, the SH2 domain of the latent transcription factor, STAT3, is recruited to phosphotyrosine in the context of a Y(P)XXQ motif [48, 49] . Understanding signaling by the LRb/Jak2 complex thus requires defining the tyrosine phosphorylation sites on LRb and Jak2 and the SH2 proteins that they recruit. There are three conserved residues on the intracellular domain of LRb-Tyr 985 , Tyr 1077 , and Tyr 1138 [9, 44, 45] . Review Article
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Phosphorylation of Tyr 1138 recruits STAT3 to the LRb/Jak2 complex, resulting in the tyrosine phosphorylation and subsequent nuclear translocation of STAT3 to mediate transcriptional regulation [44, 45] . Among other genes, STAT3 mediates the transcription of the SH2 domaincontaining feedback inhibitor, suppressor of cytokine signaling (SOCS)-3 [45, 51] . SOCS3 binds to Tyr 985 of LRb to mediate inhibition of LRbAESTAT3 signaling [52] ; SOCS3 also binds to a separate site on Jak2 itself [53, 54] . The relative importance of these two binding sites and the contribution of the Tyr 1138 AESTAT3 pathway to the generation of SOCS3 levels in LRb-expressing tissues in vivo are not known at this time. Jak2 tyrosine phosphorylation during LRb stimulation mediates some signals independently of tyrosine phosphorylation sites on LRb (e.g. a portion of ERK activation) [45] . The individual tyrosine phosphorylation sites on Jak2 are beginning to be enumerated [55] [56] [57] [58] [59] , but many more remain to be identified, and the binding partners and signals mediated by many sites are not known, limiting our understanding of the mechanisms by which Jak2-dependent signals are mediated. LRb stimulation mediates the tyrosine phosphorylation of insulin receptor substrate (IRS) proteins and activation of the phosphoinositide (PI) 3¢-kinase pathway [60] , presumably via tyrosine phosphorylation sites on Jak2. Although the exact mechanisms by which Jak2 mediates activation of the IRS-proteinAEPI 3-kinase pathway is not understood, it is clear that this pathway represents an important component of leptin action in vivo as well as an important area of crosstalk with insulin signaling [60] [61] [62] [63] [64] .
LRb signaling in the regulation of physiology
Thus far, two LRb signaling pathways have been implicated in leptin action: STAT3 (see below), and the IRS proteinAEPI 3¢-kinase pathway. First described as insulin receptor substrates, the IRS proteins (IRS-1-4), are members of a class of intracellular signaling molecules termed docking proteins that are phosphorylated by several tyrosine kinases (e.g. insulin receptor and some cytokine receptors) [65] . Docking proteins, including the IRS, are devoid of enzymatic activity, but are phosphorylated on multiple tyrosine residues to mediate SH2-protein recruitment and downstream signaling. Although IRS proteins contain tyrosine phosphorylation sites in numerous motifs that recruit several different SH2 proteins, most sites lie in YMXM motifs that bind and activate PI 3¢-kinase. The first, albeit indirect, evidence for a potential role of the IRS proteinAEPI 3¢-kinase pathway in leptin action came from the phenotype of the IRS-2 null (IRS-2 -/-) mouse [66, 67] . In addition to other defects, IRS-2 -/-animals display increased feeding and decreased metabolic rate in the presence of increased adiposity and circulating leptin, suggesting functional leptin resistance (although it is not as severe as in db/db animals) [67] . No such phenotype has been noted in animals null for any of the other three IRS proteins [68] , suggesting a specialized role for IRS-2 in anorectic signaling. Blockade of PI 3¢-kinase activity abrogates leptinmediated hyperpolarization/inhibition of (presumably) LRb/NPY/AgRP hypothalamic neurons [69, 70] . Furthermore, leptin stimulates IRS-2-associated PI 3¢-kinase activity in the hypothalamus, and pharmacological blockade of PI 3¢-kinase activity in the hypothalamus blocks the anorectic effect of leptin in vivo [60] . PI 3¢-kinase activity is also required for leptin-regulated sympathetic nervous system function [71] . It will be interesting to determine both the role of this pathway in leptin resistance and the neuropeptide phenotype of the neuronal population(s) in which PI 3¢-kinase activity is required for the anorectic actions of leptin and insulin, as well as the role of PI 3¢-kinase in other leptin functions (e.g. neuroendocrine and immune regulation). 
LRb signaling via STAT3 mediates a subset of leptin actions
We have directly addressed the contribution of the LRb-STAT3 pathway to physiology by studying homologously targeted 'knock-in' mice in which LRb is replaced by a mutant molecule (LRb S1138 ) that contains a substitution mutation of Tyr 1138 (the STAT3 binding site) [72] . Although LRb S1138 fails to mediate activation of STAT3 during leptin signaling, this mutant regulates all other LRb signaling pathways normally. The use of the 'knockin' approach ensures that the expression pattern and levels of LRb S1138 mirror that of wild-type LRb. This system has several advantages over other approaches such as the ablation of STAT3 using neural-specific expression of Cre recombinase in combination with conditional alleles of STAT3 [73] , as STAT3 is required for signaling by numerous receptors (other than LRb) critical to brain function, and the approach of STAT3 ablation cannot be specific for LRb action even if it were specific for LRb neurons. Similar to db/db animals, mice homozygous for LRb S1138 expression (s/s) display hyperphagia and decreased energy expenditure, resulting in profound obesity that is associated with increased serum leptin levels. The high circulating leptin levels in s/s animals not only correlate with increased adipose mass in these mice, but also indicate resistance to the energy homeostatic effects of leptin [72] . Feeding is similarly high in s/s and db/db mice, and energy expenditure is decreased identically in these two mouse strains [74] . There is evidence that leptin regulates thyroid function via both direct and indirect pathways [17, [75] [76] [77] [78] ; each of these appear to be STAT3 dependent, as the thyroid function of s/s and db/db mice is similarly depressed [74] . Similarly, energy expenditure mediated by the activity of the sympathetic nervous system is similarly depressed in s/s and db/db mice by the assay of uncoupling protein-1 expression in brown adipose tissue [74] . Important differences exist between the phenotypes of s/s mice (missing only the LRb-STAT3 signal) and db/db mice (devoid of all leptin signals), however [72] . Whereas db/db animals are floridly diabetic, infertile and demonstrate decreased linear growth, s/s mice demonstrate greatly improved glucose tolerance compared to db/db mice, retain relatively normal gonad function and demonstrate increased linear growth compared with wild-type animals. Analysis of hypothalamic neuropeptide expression reveals that, similar to db/db mice, s/s mice have decreased POMC and increased AgRP mRNA levels in the hypothalamus [72] . By contrast, whereas db/db animals display dramatic induction of hypothalamic NPY mRNA, levels of NPY message are near normal in s/s animals. These data suggest that LRb-STAT3 signaling is a crucial regulator of hypothalamic melanocortin action, and that dysregulated melanocortin signaling (as opposed to alterations in NPY) contributes to the obesity of s/s animals. Hence, non-STAT3 LRb signals are critical regulators of NPY expression in the LRb/NPY neuron. Additionally, STAT3 is not likely to be involved in the regulation of membrane potential in ARC neurons, since leptin-regulated membrane potential is too rapid to be mediated by the transcriptional action of STAT3 [29, 69] . Clearly, LRbAESTAT3-independent pathways regulate glycemic control, reproduction, growth and NPY levels in response to leptin. It is also important to note, however, that the phenotype of the s/s animals does not suggest the irrelevance of non-STAT3 pathways in energy balance, only that STAT3 signaling is important for the regulation of energy homeostasis. Thus, Tyr 1138 AESTAT3-independent signals mediated by Tyr 985 or Jak2 may contribute to energy balance as well as to glycemic control, growth and reproductive function. Indeed, PI 3¢-kinase activity as well as STAT3 signaling is required for the regulation of feeding and sympathetic nervous system activity by leptin [60, 61, 71, 72, 74] , implying a crucial role for Jak2-dependent, LRb tyrosine phosphorylation site-independent signals in leptin action in vivo. We speculate that the Jak2-IRS protein-PI 3¢-kinase pathway represents a major STAT3-independent mediator of LRb action. Data from numerous laboratories suggest that PI 3¢-kinase action regulates membrane potential in the LRb/NPY neuron [70, 79] ; PI 3¢-kinase action might similarly control membrane potential in the LRb/POMC neuron. We cannot rule out the possibility that other uncharacterized signals activated by Jak2 tyrosine phosphorylation sites could control NPY expression and/or membrane potential, however.
Leptin resistance and obesity
Obesity is a growing health problem in the western world and is a major risk factor for type 2 diabetes and cardiovascular disease [80] . Following the discovery of leptin, it was initially hoped that exogenous leptin therapy might induce satiety and weight loss in humans [1, 2, 9, 12, 16] . Indeed, as in rodents, leptin administration results in reduced appetite and neuroendocrine normalization in (rare) obese leptin-deficient patients [81] [82] [83] . Furthermore, leptin was found to be efficacious for the treatment of the hyperphagia and endocrine abnormalities that result from the reduced leptin levels in rodents and humans with very low body fat content due to a number of lipodystrophic [84] [85] [86] and eating disorders [87] . Indeed, leptin therapy appears to ameliorate the reduced energy expen-CMLS, Cell. Mol. Life Sci. Vol. 62, 2005 Review Article 647 diture and increased hunger associated with weight loss in humans [82, [88] [89] [90] [91] [92] . Unfortunately, the scale of the weight loss achieved with leptin therapy in most obese humans was modest compared to the expectations of most observers. While this limited response may result in part from the modest doses of leptin that can be administered to humans (in contrast to obese rodents) due to the induction of a local inflammatory reaction by subcutaneous leptin injection, it is also clear that most obese individuals exhibit elevated circulating levels of leptin as a consequence of their increased fat mass, but do not adequately respond to this elevated leptin with reduced food intake. This under-responsiveness to endogenous and exogenous leptin in most forms of human obesity has given rise to the idea that obesity is associated with or even caused by a state of relative leptin resistance, similar to the insulin resistance of type 2 diabetes.
Leptin resistance -transport defects versus signaling defects
Some investigators have argued against the validity of the concept of leptin resistance, as the physiologic and evolutionarily selected role of leptin is believed to signal undernutrition at low levels rather than preventing overnutrition at high levels. While the evolutionary basis of this argument appears sound, there are examples in nature of temporary leptin resistance, e.g. in seasonal mammals and during pregnancy conditions where food intake must be increased despite elevated body fat and leptin levels [93, 94] . Furthermore, the finding that high doses of leptin can somewhat reduce feeding in rodents with dietinduced obesity suggests that increased leptin action can be obtained with superphysiolgic doses of leptin and that leptin action does not reach an upper limit within the physiologic range of concentrations [95] . With regard to the pathology of human obesity the major goal therefore is to understand the mechanism(s) triggering leptin resistance, the nature of the processes and molecules that limit action in hyperleptinemic states, and how to bypass these limitations on leptin action. The identity of the crucial mediator(s) of leptin resistance still remains unclear, but possibilities that have received a good deal of attention include the failure of circulating leptin to reach its targets in the brain and inhibition of the intracellular LRb signaling cascade. The mechanism(s) by which leptin gains access to the brain is still a matter of debate; some have proposed that the movement of leptin into the brain to regulate energy balance is mediated via a specific transport mechanism across the blood brain barrier (BBB) and/or via the circumventricular organs (CVO) [e.g. the median eminence (ME)]. Leptin is clearly transported across the BBB by a saturable transport system that may be in part mediated by short LR forms [96] . In rats lacking all leptin receptor isoforms, there is a marked decrease in leptin transport rate from the circulation into the brain [97] . Consistently, db/db mice that lack only LRb but have intact short LRs show normal leptin transport rates into the brain [98] . Decreased leptin transport across the BBB has also been demonstrated in diet-induced-obese (DIO) rodents -a classical model of obesity and leptin resistance in which rodents are made obese by high fat feeding [99] . Furthermore, although leptin-induced signaling to STAT3 is decreased in response to administration of peripheral leptin in DIO animals, central injection of leptin at least partially restores STAT3 activation [100] . While it is possible that the observed differences in the efficacy of central and peripheral leptin injection in DIO could reflect the difficulty of selecting doses of leptin that are directly comparable via these disparate routes of administration, it is also possible that central injection of leptin effectively bypasses a defect in leptin transport across the BBB in DIO. Whether or not defective leptin transport across the BBB contributes to leptin resistance, it is clear that the ability of leptin to activate hypothalamic signaling is decreased in DIO. A number of investigators, including us, have thus begun to examine mechanisms of LRb signal attenuation in cultured cells and in vivo. At this juncture, a wealth of data supports roles for two inhibitory molecules in the regulation of LRb signaling: SOCS3 and the protein tyrosine phosphatase, PTP1B [51, 52, 95, [100] [101] [102] [103] [104] . Overexpression of each of these proteins in cultured cells Leptin signaling and resistance attenuates leptin signaling, and there are data from genetically altered mice to suggest roles for these molecules in the inhibition of LRb signaling. Mice null for PTP1B are not only insulin sensitive, as first reported, but are lean and somewhat hypophagic with no noted neuroendocrine abnormalities [101] [102] [103] , suggesting increased leptin sensitivity may actually underlie the metabolic phenotype of these animals. Indeed, several lines of in vivo data suggest that at least part of the lean phenotype of these animals is secondary to enhanced hypothalamic leptin action. A role for SOCS3 in limiting LRb action in vivo has been implied by the finding of elevated SOCS3 in some rodent models of obesity, as well as the recent demonstration of leanness and leptin sensitivity in mice haploinsufficient for SOCS3 and in mice lacking SOCS3 in the CNS [51, 95, 104] (complete knockout of SOCS3 is lethal due to the role of SOCS3 in limiting signaling by multiple cytokine receptors) [105] [106] [107] [108] [109] . Clearly, these data suggest that PTP1B and SOCS3 are important physiologic determinants of LRb signal strength, although their potential dysregulation in obesity is not known. While no in vivo data are available to examine the potential role of the related SOCS1, expression of SOCS1 in cultured cells also interferes with LRb signaling [104] . While LRb has not been shown to regulate the expression of PTP1B, the LRbAESTAT3 pathway stimulates SOCS3 expression [45, 51, 52] , prompting the suggestion that high levels of leptin may induce SOCS3 expression and thus the attenuation of LRb signaling in obesity. Indeed, hypothalamic expression of SOCS3 is elevated in several rodent models of obesity [51] , suggesting that some signal related to obesity induces the expression of SOCS3 in leptin-sensitive neurons. The idea that leptin itself would stimulate SOCS3 expression to induce leptin insensitivity in vivo has met with resistance on theoretical grounds: this increase in SOCS3 should inhibit LRb signaling, in turn decreasing the expression of SOCS3. Thus, how could inhibitory levels of SOCS3 be maintained if leptin itself induces them? Certainly, however, leptin does induce the expression of SOCS3 in cultured cells and in vivo, and leptin-mediated induction of SOCS3 does correlate with the attenuation of LRb signaling in cultured cells [45, 51, 52] . We hypothesize that the function of this LRbAESOCS3 pathway in vivo could explain the diminishing effectiveness of increasing leptin concentrations in obesity. This hypothesis suggests that at low baseline concentrations of leptin, incremental changes in leptin would be almost fully translated into increased LRb signaling, while at high circulating levels (as in obesity), the increased expression of SOCS3 would mitigate most of the increase in LRb signaling. Indeed, numerous data from cultured cells suggest that chronic high-level LRb activation induces its own feedback inhibition, probably via SOCS3 [45, 51, 52] , effectively limiting the efficacy of high concentrations of leptin during chronic exposure.
It is certainly possible that other signals may increase SOCS3 expression of and/or other mediators of leptin resistance in vivo, however; these other potential inducers of SOCS3 expression include inflammatory mediators and cytokines such as IL-6 and tumor necrosis factor a (TNFa), fatty acids and other lipids, and activators of counter-regulatory signals such as corticosteroids.
Insights from the anatomic specificity of leptin resistance
The anatomic distribution of leptin insensitivity was recently investigated in DIO mice by examining the activation of STAT3 signaling by peripheral leptin [110] .
Both by immunohistochemistry and in microdissected nuclei from the hypothalamus, it was clear that this leptin signal was primarily attenuated in the ARC, whereas other hypothalamic and extra-hypothalamic sites remained leptin sensitive. In addition, this site-specific resistance correlated with increased expression of SOCS3 in the ARC relative to other hypothalamic nuclei (e.g. the VMH/DMH), suggesting a role for SOCS3 expression in the ARC in the development of leptin resistance. These findings are consistent with previous findings that suggest a selectivity of leptin resistance: Correia et al. [111] showed that obese leptin-resistant A y mice appropriately increased their sympathetic nervous system activity in response to exogenously applied leptin, but failed to decrease their body weight or food intake in response to leptin. ARC-restricted leptin resistance in the brain has also been observed in two natural and reversible models of leptin resistance -pregnant rats and seasonal hamsters (which exhibit a natural annual body weight cycle) [93, 94] . In each of these models, increased body fat and food intake are important for survival, and leptin resistance in these models is therefore beneficial. In both cases the ARC seems to be the major site showing leptin resistance, suggesting the ARC as the most important site in the development of leptin resistance. Furthermore these data suggest that leptin resistance can represent a regulatory rather than a pathological event in response to specific energy needs. How might the ARC leptin signaling system be singled out for leptin resistance? While the brain is generally protected from circulating factors by the BBB, secretory neurons in the hypothalamus must be in open communication with blood capillaries in order to effect the secretion of their hormones, and this contact with the circulation may also allow these neurons to sense blood-borne factors [112] . Furthermore, the ME, part of the CVO, lacks the typical BBB [113] , and the ARC is closely apposed to the ME. Indeed, the ARC of young mice is specifically sensitive to the neurodegenerative effects of peripherally applied monosodium glutamate (MSG), sug-gesting that the ARC is accessible to circulating molecules, at least in juveniles [114] . Some authors have suggested that leptin does not pass through the BBB in order to gain access to the basomedial hypothalamus [115] By extension, the finding of selective leptin resistance in the ARC, where the movement of leptin or other mediators across the BBB may not be required in order to access LRb-expressing neurons, suggests that leptin resistance may not be secondary to defective leptin transport. Indeed, it is possible that the limitations of the transport of leptin and/or other stimulators of leptin resistance across the BBB into sites other than the ARC could protect these sites from leptin resistance, while the ARC is continually exposed to them.
Summary
The function of leptin as we currently understand it is to de-emphasize feeding and permit energy expenditure when body energy stores are replete. We have learned a great deal about the mechanisms of leptin action via LRb signaling and are beginning to understand a variety of neural circuits regulated by leptin. There remain, however, a number of substantial voids in our knowledge regarding LRb signals that likely control important aspects of mammalian physiology and regarding numerous poorly characterized populations of leptin-regulated neurons in the CNS. Furthermore, although we are beginning to understand some of the mechanisms that limit LRb action in vivo (e.g. PTP1B, SOCS3), the relevance of these molecules to common obesity is not clear; nor is the function of these molecules and/or the BBB to the development of leptin resistance. The elucidation of these mechanisms over the next few years will hopefully reveal molecular details of the processes that contribute to the development of obesity.
